Celgene Corporation Contingent Value Rights
CELGZ
CELGZ was delisted on the 29th of November, 2019.
22 hedge funds and large institutions have $1.25M invested in Celgene Corporation Contingent Value Rights in 2017 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 4 closing their positions.
1% less capital invested
Capital invested by funds: $1.25M → $1.25M (-$6.77K)
15% less funds holding
Funds holding: 26 → 22 (-4)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Creative Planning
Overland Park,
Kansas
|
+$1.09K |
| 2 |
BWM
Baystate Wealth Management
Boston,
Massachusetts
|
+$22 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$23K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
-$20K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$19.5K |
| 4 |
FA
FCG Advisors
Chatham,
New Jersey
|
-$1.01K |
| 5 |
California Public Employees Retirement System
Sacramento,
California
|
-$984 |
CELGZ Hedge Fund Activity: Q1 2017 in Review
22 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Celgene Corporation Contingent Value Rights (CELGZ) for Q1 2017, worth a combined $1.25M — down 0.54% from $1.25M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of CELGZ and 1 opened new positions — a net loss of 3 holders — while 3 trimmed existing stakes and 1 added.
The largest buyer was Creative Planning, adding an estimated $1.09K. The largest seller was Citadel Advisors, exiting entirely with an estimated $23K sold.
- 22 institutional investors held Celgene Corporation Contingent Value Rights (CELGZ) as of Q1 2017, down from 26 in Q4 2016.
- Funds reported $1.25M of Celgene Corporation Contingent Value Rights stock for Q1 2017, down 0.54% quarter-over-quarter.
- 1 fund opened new Celgene Corporation Contingent Value Rights positions in Q1 2017 and 4 closed out, a net change of -3 holders.
- The largest Celgene Corporation Contingent Value Rights buyer in Q1 2017 was Creative Planning, an estimated $1.09K added.
- The largest Celgene Corporation Contingent Value Rights seller in Q1 2017 was Citadel Advisors, an estimated $23K sold.
Based on aggregated 13F filings for Q1 2017.